
|Videos|December 2, 2021
Dr. Kutikov on optimal use of blue light cystoscopy with Cysview
Author(s)Urology Times staff
"I think for the right patient, Cysview technology has a big deliverable,” says Alexander Kutikov, MD, FACS.
Advertisement
In this video, Alexander Kutikov, MD, FACS, discusses his own experience using Cysview and what he has found to be the most optimal conditions for using this technology. Kutikov is the chief of the division of urology and urologic oncology, professor in the department of surgical oncology, and the Roberta R. Scheller Chair in urologic oncology at the Fox Chase Cancer Center at Temple University in Philadelphia, Pennsylvania.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












